Upon placement of Essure, ideally 3 to 8 outer coils of the expanded Essure microinsert should be trailing into the uterus (Figure 6). A follow-up hysterosalpingogram (HSG) three months after placement of the device is a safe method of confirming …

Essure-related complications may be rare but often misdiagnosed. They may lead to adverse events and device malfunction such as unwanted pregnancies and chronic pelvic pain.

In most cases, abdominal displacement of the microinsert is asymptomatic and does not induce tissue damage. However, in some cases, it may cause a severe adverse event, requiring major surgery. Therefore, removal of the migrated device should be performed as soon as possible.

Mar 5, 2025 · The patient has history of tubal ligation with Filshie® clips and Essure® coils to occlude the fallopian tubes to prevent pregnancy. She now presents for removal of displaced tubal occlusion devices.

Essure is a form of permanent birth control that can be performed in an office setting and does not require incisions or general anesthesia. It involves the placement of spring-like devices into the proximal section of each fallopian tube via hysteroscopy.

Jul 15, 2019 · Essure is a hysteroscopic sterilization technique involving placement of nickel-titanium microinserts in the fallopian tubes. Over the course of 12 weeks, the microinserts cause fibrosis and occlusion of the fallopian tubes.

Oct 24, 2018 · We have tested a new method for Essure reversal using a laparoscopic approach that does not require a large abdominal or uterine incision. With this method, laparoscopy and hysteroscopy are performed simultaneously to remove the device and reimplant the distal fallopian tube into a new site on the uterine fundus.

Oct 4, 2012 · Some complications of coil (Essure device) placement, such as tubal perforation and device migration, may be clinically occult and their imaging appearances subtle; a high degree of suspicion is needed to detect them at postprocedural imaging.

Mar 3, 2016 · While contraindications to Essure® placement have been provided by the manufacturer, there is no consensus on how best to remove these contraceptive devices. Here, we describe a non-hysterectomy removal of Essure® for a patient with a septate uterus (ESHRE Class IIb uterine malformation).

In 2019, Essure was discontinued, and Bayer voluntarily removed it from the market. Due to the problematic history of Essure, many women have requested that their devices be removed. Dr. Khamvongsa uses three methods to do this: laparoscopic extraction, open laparotomy, and hysteroscopic removal.